Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine:: II.: In vitro studies in the rat

被引:20
作者
Béïque, JC [1 ]
de Montigny, C [1 ]
Blier, P [1 ]
Debonnel, G [1 ]
机构
[1] McGill Univ, Dept Psychiat, Neurobiol Psychiat Unit, Montreal, PQ H3A 1A1, Canada
基金
英国医学研究理事会;
关键词
antidepressant; reuptake inhibitors; 5-MT1B receptors; adrenergic receptors; hippocampus; in vitro superfusion; autoreceptors;
D O I
10.1016/S0028-3908(00)00018-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The effects of long-term administrations of a low (10 mg/kg/day) and a high (40 mg/kg/day) dose of the dual 5-HT and NE reuptake inhibitor venlafaxine (delivered s.c. by osmotic minipumps for 21 days) were assessed on the electrically-evoked release of tritium from hippocampal slices preloaded with either [H-3]5-HT or [H-3]NE, 48 h after the removal of the minipump. The high, but not the low, dose regimen of venlafaxine enhanced the electrically-evoked release of [H-3]5-HT while treatment with the high dose of venlafaxine failed to alter the electrically-evoked release of [H-3]NE. The inhibitory effect of the 5-HT1B agonist CP 93,129 on the electrically evoked release of [H-3]5-HT was unaltered by the low dose regimen of venlafaxine;while it was attenuated in rats treated with the high dose of venlafaxine, indicative of a functional desensitization of the terminal 5-HT1B autoreceptor. Unexpectedly, neither regimen of venlafaxine altered the inhibitory effect of UK 14,304 on the electrically evoked release of both [H-3]5-HT and [H-3]NE, indicating that neither the alpha(2)-adrenergic auto- nor heteroreceptors were desensitized. Finally, the functions of the 5-HT and NE reuptake process were assessed. None of the treatment regimens altered the basal uptake of [H-3]5-HT from hippocampal or mesencephalic slices nor that of [H-3]NE from hippocampal slices. Finally, the enhancing effect of 1 mu M of paroxetine in the perfusion medium on the electrical release of [H-3]5-HT was unaltered in hippocampal slices prepared from rats that had been treated for 21 days with 40 mg/kg/day of venlafaxine. Taken together, these results indicate that, in terms of alteration of the sensitivity of the terminal 5-HT1B autoreceptor, alpha(2)-adrenergic auto-and heteroreceptors, the effects of long-term administration of venlafaxine are no different than those observed with classical SSRI's. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1813 / 1822
页数:10
相关论文
共 40 条
[31]   EFFECT OF MILNACIPRAN AND DESIPRAMINE ON NORADRENERGIC ALPHA(2)-AUTORECEPTOR SENSITIVITY [J].
MORET, C ;
BRILEY, M .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1994, 18 (06) :1063-1072
[32]   ANTIDEPRESSANT BIOCHEMICAL PROFILE OF THE NOVEL BICYCLIC COMPOUND WY-45,030, AN ETHYL CYCLOHEXANOL DERIVATIVE [J].
MUTH, EA ;
HASKINS, JT ;
MOYER, JA ;
HUSBANDS, GEM ;
NIELSEN, ST ;
SIGG, EB .
BIOCHEMICAL PHARMACOLOGY, 1986, 35 (24) :4493-4497
[33]  
NIERENBERG AA, 1994, J CLIN PSYCHOPHARM, V14, P419
[34]  
PINEYRO G, 1994, J NEUROSCI, V14, P3036
[35]   Effect of long-term administration of duloxetine on the function of serotonin and noradrenaline terminals in the rat brain [J].
Rueter, LE ;
Kasamo, K ;
de Montigny, C ;
Blier, P .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 357 (06) :600-610
[36]   PRESYNAPTIC ALPHA2-ADRENOCEPTOR AND POSTSYNAPTIC BETA-ADRENOCEPTOR SENSITIVITY IN SLICES OF RAT NEOCORTEX AFTER CHRONIC TREATMENT WITH VARIOUS ANTIDEPRESSANT DRUGS [J].
SCHOFFELMEER, ANM ;
HOORNEMAN, EMD ;
SMINIA, P ;
MULDER, AH .
NEUROPHARMACOLOGY, 1984, 23 (2A) :115-119
[37]   SUCCESS OF HEARING-AID FITTING IN NURSING-HOMES [J].
SCHOW, RL .
EAR AND HEARING, 1982, 3 (03) :173-177
[38]  
SCHWEIZER E, 1991, J CLIN PSYCHOPHARM, V11, P233
[39]   MODULATION OF NEUROTRANSMITTER RELEASE BY PRESYNAPTIC AUTORECEPTORS [J].
STARKE, K ;
GOTHERT, M ;
KILBINGER, H .
PHYSIOLOGICAL REVIEWS, 1989, 69 (03) :864-989
[40]   Changes in the regulation of 5-hydroxytryptamine release by alpha(2)-adrenoceptors in the rat hippocampus after long-term desipramine treatment [J].
Yoshioka, M ;
Matsumoto, M ;
Numazawa, R ;
Togashi, H ;
Smith, CB ;
Saito, H .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 294 (2-3) :565-570